Deven Robinson
Psychiatric/Mental Health · Whitefish, MTNPI 1437565629
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $340 of the $389 with a category attached, or 87.4%. 11 manufacturers reported payments, led by AbbVie at 26.9% of the total. 2025 is the largest year on record at $150, 4.7 times the $32 reported in 2021.
Across 18 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$105
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$49
- Neurocrine Biosciences, Inc.$44
- Sunovion Pharmaceuticals Inc.$40
- Supernus Pharmaceuticals, Inc.$35
- Vanda Pharmaceuticals Inc.$29
- plus $87 from 5 others
What the payments were for
- Food & beverage$34087%
- Education$4913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$389 in reported general payments places this provider in the 75th percentile of 142 psychiatric/mental health providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 20 | $4,902 |
| Quetiapine Fumarate | 63 | $3,192 |
| Divalproex Sodium ErDivalproex Sodium | 29 | $1,587 |
| Bupropion XlBupropion Hcl | 27 | $658 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $522 |
| Fluoxetine Hcl | 61 | $519 |
| Prazosin Hcl | 30 | $388 |
| Escitalopram Oxalate | 39 | $359 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $294 |
| Duloxetine Hcl | 21 | $182 |
| Mirtazapine | 20 | $166 |
| Sertraline Hcl | 40 | $148 |
| Trazodone Hcl | 22 | $143 |
| Buspirone Hcl | 17 | $143 |
| Benztropine Mesylate | 12 | $133 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Whitefish
- Tommie PerusichButte$4K
- Heather BrownKalispell$3K
- Sherry MartinMissoula$3K
- Jill DonaldsonGreat Falls$3K
- Jennifer DurwardHavre$2K
- William BowdenGreat Falls$2K
- Susan FinnBillings$2K
- Elizabeth HollingsworthButte$1K
- Danielle BertramButte$1K
- Kindra ParksButte$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.